Clinical Trial Update: Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on dapagliflozin and hydrochlorothiazide in patients with recurring kidney stones (urolithiasis) and hyperoxaluria; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria
• Urolithiasis

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Medical University of Vienna | Conditions: Urolithiasis, Hyperoxaluria | Phase 4 | Status: UNKNOWN